MOVING
​FORWARD

We first seek to understand your company, mission and values. What is your role in the life science ecosystem? Mission, vision and values must be aligned with your CPXM vision, and be reflected in actions to your patients and customers. This will drive priorities, focus, responses. We need to make sure the experiences you are creating are aligned.

Establishing relationships when developing and assessing new products might be adapted per therapeutic area. Different areas, and franchises, have different participants with different needs. The success of research, clinical studies, product launches, global approaches, depend on your target therapeutic areas. Your approach will be product specific.

Regulations for life science actors must be reflected in CPXM activities. From basic marketing regulations to detailed product and therapeutic regulations, they depend on customer and patient segments and processes. Different global and local regulations might call for different solutions ensuring compliance. Critical to understand what we need to comply with.

Every company has a different level of business maturity. CPXM needs to be adopted in line with the company's growth path. When you are in start-up or development, requirements are different compared to large manufacturers. When the nature of your customers starts to change depending on your business maturity, your CPXM strategy should evolve as well.

Who are your key customers? What are the specific patient profiles? 

Which are leading and growing segments? CPXM considers end-to-end stakeholders such as medical practitioners, advisory boards, advocacy groups, clinical trail investigators, hospital leads, physicians, nurses, payers. Getting the right segments and adopting your strategy to them, is the basis of customer and patient centricity.

Each development state has different patient and customer journeys. Examples of touchpoints that depend on the state of your products: advisory boards, patient recruitment, technology transfer facilitation, supply chain efficiency, commercial relationship building. Capturing patient perspectives in a clinical trial is different from using approved products. Understand what expectations they have now.

There is a wide scale of leading digital solutions that target specific needs; the more focused for specific cases, the higher the benefits of using the technology. In terms of new innovations, the spectrum of options is growing on a daily basis. Technologies are to be integrated with different data sets along the ecosystem. Where do you stand today and which areas of business represent the challenges.

Within companies, the levels of adoption are widely different between markets, entities, divisions and franchises. Your CPXM strategy and approach should take into account the current levels of CPXM maturity and adoption. How well are the organizational culture and your people aligned? We help you to assess so we ensure the value of our engagement is in line with the current adoption level.